Medpace Holdings, Inc.
Simbol: MEDP
NASDAQ
392.57
USDTržna cena danes
38.7448
Razmerje P/E
0.0000
Razmerje PEG
12.16B
Kapaciteta MRK
- 0.00%
Donos DIV
Medpace Holdings, Inc. (MEDP) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 786.8 | 245.4 | 28.3 | 461.3 | ||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.net-receivables | 1145.4 | 298.4 | 253.4 | 186.4 | ||||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.other-current-assets | 234.34 | 50 | 52.3 | 43.2 | ||||||||||
balance-sheet.row.total-current-assets | 2166.54 | 593.8 | 334 | 690.9 | ||||||||||
balance-sheet.row.property-plant-equipment-net | 1036.38 | 265.4 | 248.9 | 222.7 | ||||||||||
balance-sheet.row.goodwill | 2649.58 | 662.4 | 662.4 | 662.4 | ||||||||||
balance-sheet.row.intangible-assets | 144.52 | 35.8 | 38 | 41.4 | ||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 2794.11 | 698.2 | 700.4 | 703.8 | ||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.tax-assets | 260.77 | 74.4 | 48.1 | 25.1 | ||||||||||
balance-sheet.row.other-non-current-assets | 88.47 | 25 | 21.1 | 17.4 | ||||||||||
balance-sheet.row.total-non-current-assets | 4179.74 | 1063 | 1018.5 | 969 | ||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-assets | 6346.28 | 1656.8 | 1352.5 | 1659.9 | ||||||||||
balance-sheet.row.account-payables | 118.9 | 31.9 | 33.1 | 25.7 | ||||||||||
balance-sheet.row.short-term-debt | 885.06 | 293 | 50 | 159.3 | ||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.long-term-debt-total | 560.71 | 142.1 | 138.9 | 131 | ||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 6.99 | - | - | - | ||||||||||
balance-sheet.row.other-current-liab | 392.9 | 40.4 | 257.7 | 27.6 | ||||||||||
balance-sheet.row.total-non-current-liabilities | 671.08 | 172.7 | 162.6 | 149.8 | ||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.capital-lease-obligations | 560.71 | 142.1 | 138.9 | 131 | ||||||||||
balance-sheet.row.total-liab | 4253.81 | 1097.9 | 966.1 | 707 | ||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.common-stock | 1.23 | 0.3 | 0.3 | 0.4 | ||||||||||
balance-sheet.row.retained-earnings | -1012 | -221.6 | -359.8 | 235 | ||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -46.18 | -10.1 | -12.4 | -4.8 | ||||||||||
balance-sheet.row.other-total-stockholders-equity | 3149.41 | 790.4 | 758.3 | 722.4 | ||||||||||
balance-sheet.row.total-stockholders-equity | 2092.46 | 559 | 386.4 | 952.9 | ||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 6346.28 | 1656.8 | 1352.5 | 1659.9 | ||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-equity | 2092.46 | 559 | 386.4 | 952.9 | ||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 6346.28 | - | - | - | ||||||||||
Total Investments | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-debt | 615.71 | 142.1 | 188.9 | 131 | ||||||||||
balance-sheet.row.net-debt | -171.1 | -103.3 | 160.6 | -330.3 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 312.51 | 282.8 | 245.4 | 181.8 | ||||||||||
cash-flows.row.depreciation-and-amortization | 27.36 | 26.3 | 22.3 | 21.1 | ||||||||||
cash-flows.row.deferred-income-tax | -24.92 | -25.1 | -23 | -37.1 | ||||||||||
cash-flows.row.stock-based-compensation | 19.39 | 20.5 | 21.4 | 14.5 | ||||||||||
cash-flows.row.change-in-working-capital | 151.12 | 106.5 | 106.1 | 66.7 | ||||||||||
cash-flows.row.account-receivables | -24.82 | -48.3 | -66.9 | -25 | ||||||||||
cash-flows.row.inventory | 43.94 | 66.2 | 0 | 25 | ||||||||||
cash-flows.row.account-payables | -10.76 | 1.1 | 6.4 | 1.9 | ||||||||||
cash-flows.row.other-working-capital | 179.05 | 87.5 | 166.5 | 64.8 | ||||||||||
cash-flows.row.other-non-cash-items | 20.52 | 22.4 | 15.9 | 16.3 | ||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 505.98 | 0 | 0 | 0 | ||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -32.63 | -36.6 | -36.9 | -28.3 | ||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.other-investing-activites | 10.04 | 2 | -1.9 | -3.1 | ||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -22.6 | -34.6 | -38.7 | -31.4 | ||||||||||
cash-flows.row.debt-repayment | -130 | -155 | -274.2 | 0 | ||||||||||
cash-flows.row.common-stock-issued | 16.57 | 11.4 | 22.1 | 17.6 | ||||||||||
cash-flows.row.common-stock-repurchased | -23.87 | -144 | -847.8 | -62.1 | ||||||||||
cash-flows.row.dividends-paid | 0 | -11.4 | -22.1 | 0 | ||||||||||
cash-flows.row.other-financing-activites | -23.43 | 116.4 | 346.3 | -44.5 | ||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -122.3 | -182.6 | -775.8 | -44.5 | ||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.99 | 1.1 | -6.6 | -4 | ||||||||||
cash-flows.row.net-change-in-cash | 360.09 | 217.2 | -433 | 183.5 | ||||||||||
cash-flows.row.cash-at-end-of-period | 786.8 | 245.4 | 28.3 | 461.3 | ||||||||||
cash-flows.row.cash-at-beginning-of-period | 426.72 | 28.3 | 461.3 | 277.8 | ||||||||||
cash-flows.row.operating-cash-flow | 505.98 | 433.4 | 388.1 | 263.3 | ||||||||||
cash-flows.row.capital-expenditure | -32.63 | -36.6 | -36.9 | -28.3 | ||||||||||
cash-flows.row.free-cash-flow | 473.34 | 396.7 | 351.2 | 235.1 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1962.81 | 1885.8 | 1460 | 1142.4 | ||||||||||
income-statement-row.row.cost-of-revenue | 1413.35 | 1361.3 | 1027.6 | 814.2 | ||||||||||
income-statement-row.row.gross-profit | 549.46 | 524.5 | 432.4 | 328.2 | ||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-general-administrative | 41.01 | - | - | - | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 1.5 | - | - | - | ||||||||||
income-statement-row.row.other-expenses | 12.98 | 1.3 | 22.3 | 21.1 | ||||||||||
income-statement-row.row.operating-expenses | 194.77 | 187.7 | 153.7 | 129.5 | ||||||||||
income-statement-row.row.cost-and-expenses | 1608.12 | 1549 | 1181.3 | 943.8 | ||||||||||
income-statement-row.row.interest-income | 3.31 | 0 | 2.9 | 0.1 | ||||||||||
income-statement-row.row.interest-expense | 7.43 | -0.5 | 2.9 | -0.1 | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 1.5 | - | - | - | ||||||||||
income-statement-row.row.total-other-income-expensenet | 1.89 | -0.7 | 4.2 | 3.2 | ||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.other-operating-expenses | 12.98 | 1.3 | 22.3 | 21.1 | ||||||||||
income-statement-row.row.total-operating-expenses | 1.89 | -0.7 | 4.2 | 3.2 | ||||||||||
income-statement-row.row.interest-expense | 7.43 | -0.5 | 2.9 | -0.1 | ||||||||||
income-statement-row.row.depreciation-and-amortization | 26.08 | 26.3 | 22.3 | 21.1 | ||||||||||
income-statement-row.row.ebitda-caps | 381.37 | - | - | - | ||||||||||
income-statement-row.row.operating-income | 354.69 | 336.8 | 278.7 | 198.6 | ||||||||||
income-statement-row.row.income-before-tax | 362.43 | 335.7 | 282.9 | 201.9 | ||||||||||
income-statement-row.row.income-tax-expense | 49.93 | 52.9 | 37.5 | 20 | ||||||||||
income-statement-row.row.net-income | 312.51 | 282.8 | 245.4 | 181.8 |
Pogosto zastavljeno vprašanje
Kaj je Medpace Holdings, Inc. (MEDP) skupna sredstva?
Medpace Holdings, Inc. (MEDP) skupna sredstva so 1656828000.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so 1009445000.000.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.280.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je 15.347.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je 0.159.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so 0.181.
Kaj je Medpace Holdings, Inc. (MEDP) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je 282810000.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 142122000.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 187680000.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 407010000.000.